HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2088879Generated: October 27, 2026
1,1-Dichloroethane → tert-butyl 4-(4,5-dichloro-1H-imidazol-2-yl)piperidine-1-carboxylate
https://huagongshe.com/reaction/2088879
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 1,1-Dichloroethane | HCID 6365 | — |
| Reactant | Chlorosuccinimide | HCID 31398 | — |
| Reactant | tert-butyl 4-(1H-imidazol-2-yl)piperidine-1-carboxylate | HCID 17840015 | — |
| Product | tert-butyl 4-(4,5-dichloro-1H-imidazol-2-yl)piperidine-1-carboxylate | HCID 67112013 | 29% |
Reaction Steps
Add tert-butyl 4-(1H-imidazol-2-yl)piperidine-1-carboxylate (6.00 g, 23.87 mmol) in dichloroethane (200 mL). Add N-chlorosuccinimide (3.19 g, 1.0 eq). Stir at room temperature under nitrogen for 14 hours. Concentrate the reaction mixture in vacuo. Purify by silica gel chromatography, eluting with hexanes to 9:1 hexanes:ethyl acetate to 4:1 hexanes:ethyl acetate to 2:1 hexanes:ethyl acetate to 1:1 hexanes:ethyl acetate, to give two major spots. Concentrate fractions containing the higher Rf spot in vacuo to give tert-butyl 4-(4,5-dichloro-1H-imidazol-2-yl)piperidine-1-carboxylate (2.25 g, 29%). MS (ES) m/z=321 [M]+. Concentrate fractions containing the lower spot in vacuo. Slurry the resulting solid into diethyl ether/chloroform, then filter. Concentrate the filtrate in vacuo to give tert-butyl 4-(4-chloro-1H-imidazol-2-yl)piperidine-1-carboxylate (1.16 g, 17%). MS (ES) m/z=286 [M]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08436002B2 |
|---|
| Source dataset | uspto-grants-2013_05 |
|---|
| ORD ID | ord-efbb5d5ee9bf4422ba3b86fb4c050ad9 |
|---|
| Source note | uspto-grants-2013_05 |
|---|